Berlin - Delayed Quote EUR
Altimmune Inc (3G0.BE)
5.06
-0.08
(-1.52%)
As of 8:04:39 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
20
20
426
-68
4,410
Operating Expense
103,192
103,192
83,936
87,672
89,954
Operating Income
-103,172
-103,172
-83,510
-87,740
-85,544
Net Non Operating Interest Income Expense
8,065
8,065
7,316
2,862
198
Other Income Expense
48
48
-12,253
-32
-11,744
Pretax Income
-95,059
-95,059
-88,447
-84,910
-97,090
Tax Provision
--
--
0
-197
0
Net Income Common Stockholders
-95,059
-95,059
-88,447
-84,713
-97,090
Diluted NI Available to Com Stockholders
-95,059
-95,059
-88,447
-84,713
-97,090
Basic EPS
-1.57
-1.34
-1.66
-1.81
-2.35
Diluted EPS
-1.57
-1.34
-1.66
-1.81
-2.35
Basic Average Shares
67,820.39
71,003.40
53,246.94
46,926.35
41,283.50
Diluted Average Shares
67,820.39
71,003.40
53,246.94
46,926.35
41,283.50
Total Operating Income as Reported
-103,172
-103,172
-95,929
-87,740
-96,914
Total Expenses
103,192
103,192
83,936
87,672
89,954
Net Income from Continuing & Discontinued Operation
-95,059
-95,059
-88,447
-84,713
-97,090
Normalized Income
-95,059
-95,059
-76,028
-84,713
-85,720
Interest Income
8,074
8,074
7,351
2,870
203
Interest Expense
9
9
35
8
5
Net Interest Income
8,065
8,065
7,316
2,862
198
EBIT
-95,050
-95,050
-88,412
-84,902
-97,085
EBITDA
-94,812
-94,812
-87,935
-84,409
-96,534
Reconciled Depreciation
238
238
477
493
551
Net Income from Continuing Operation Net Minority Interest
-95,059
-95,059
-88,447
-84,713
-97,090
Total Unusual Items Excluding Goodwill
0
0
-12,419
0
-11,370
Total Unusual Items
0
0
-12,419
0
-11,370
Normalized EBITDA
-94,812
-94,812
-75,516
-84,409
-85,164
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/26/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1IJA.MU Adicet Bio Inc
0.5870
-4.24%
HPHA.BE Heidelberg Pharma AG
3.2700
+3.48%
473A.SG Adaptimmune Therapeutics PLC
0.2360
-1.67%
41X.F Ardelyx, Inc.
2.8850
-3.64%
MDG1.F Medigene AG
0.1090
-5.63%
VVY.AS Vivoryon Therapeutics N.V.
1.7540
-0.23%
FYB.DE Formycon AG
23.20
+0.22%
IDYA IDEAYA Biosciences, Inc.
17.10
-2.01%
SCPH scPharmaceuticals Inc.
2.2400
-3.45%
CVAC CureVac N.V.
3.3700
-0.74%